Xatral Trademark Details

Xatral was registered on Tuesday, April 1, 1986 and is currently owned by Sanofi-Aventis under the registration number 1387997 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 17 years ago on Saturday, January 6, 2007, according to the United State Patent & Trademark Office
Word Mark Xatral
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Sanofi-Aventis of Allen, TX

View all trademarks for Sanofi-Aventis
Other Trademarks for Sanofi-Aventis

Previous Owners

Synthelabo

View all trademarks for Synthelabo
Serial Number 73551057
Registration Number 1387997
Status Date Saturday, January 6, 2007
Filing Date Saturday, January 6, 2007
Registration Date Tuesday, April 1, 1986
Attorney Susan Upton Douglass
Domestic Representative Weiss Dawid Fross Zelnick & Lehrman, PC

Correspondent

SUSAN UPTON DOUGLASS
WEISS DAWID FROSS ZELNICK & LEHRMAN, PC
633 THIRD AVENUE
NEW YORK, NEW YORK 10017

Case File Statements

Goods & Services Pharmaceutical Preparation for the Treatment of the Cardiovascular and Urological Systems

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 018
Status 2 — Sec. 8 – Entire Registration
Status Date Saturday, January 6, 2007
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.